Use Of Ginsenoside M1 For Preventing Or Treating Silicosis
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 理筱龙
- Publication Date
- 2018-01-26
Smart Images
Figure 1 
Figure 2 
Figure 3
Abstract
Description
[0001] related application
[0002] This application claims priority to US Provisional Application No. 62 / 134,236, filed March 17, 2015, the contents of which are hereby incorporated by reference in their entirety. technical field
[0003] The invention relates to a new application of ginsenoside M1 for treating or preventing silicosis. Background technique
[0004] Silicosis is a lung disease caused by inhalation of silica particles, usually from working in mines and quarries and some other occupations such as construction, foundries, ceramics and glass manufacturing. Silica particles affect lung function. Symptoms include shortness of breath, severe coughing, and weakness.
[0005] Ginsenosides, the main active ingredients of ginseng, are known to have various pharmacological activities, such as antitumor, antifatigue, antiallergic, and antioxidant activities. Ginsenosides have the same basic structure, which is composed of a gonane steroid nucleus with 17 carbon atoms ...